Richard Kennedy, PhD

Richard Kennedy, PhD

Associate Dean for Research, and the Vice President of the Beaumont Research Institute

Professor of Biomedical Sciences

Oakland University William Beaumont School of Medicine
2200 N. Squirrel
Rochester, Michigan   48309

Phone: 248.370.2767

Education and Training

Michigan State University,
Postdoctoral training in the Department of Pharmacology & Toxicology, 1981 and 1983

University of Nebraska Medical Center,
PhD, 1981

St. Louis College of Pharmacy,
Bachelor of Science in pharmacy, 1975

Memberships and Certifications

  • American Association for the Advancement of Science Council on Basic Science - American Heart Association
  • American Society for Pharmacology and Experimental Therapeutics
  • International Society for Heart Research
  • American Physiological Society
  • American Association for Pharmaceutical Sciences
  • AAMC Group on Research Advancement and Development (GRAND) Program Committee 
  • AAHC Executive Leadership Group of Vice Presidents for Research
  • AAMC Group on Graduate Research, Education and Training (GREAT)

Dr. Richard Kennedy joined the faculty at the University of Arkansas for Medical Sciences (UAMS) and rose through the academic ranks from instructor to full professor in the Department of Pharmacology & Toxicology between 1983 and 1997. From 1995 to 1997 he also served half time as the vice president for EPSCoR Research at the Arkansas Science and Technology Authority, a state agency focusing on the development of a competitive statewide research infrastructure. In 1998, he assumed chairmanship of the newly combined Department of Pharmaceutical Sciences in the School of Pharmacy at UAMS, and in 2002 he also became dean of the Graduate School at that institution. He moved to Loyola in 2004.

He has been the major adviser for eight doctoral students, including one combined MD/PhD recipient, and has trained three postdoctoral students, numerous medical students doing research projects, and three clinical fellows. His research in cardiovascular pharmacology and pathophysiology has resulted in more than 105 peer-reviewed manuscripts and has been funded by a variety of agencies including the National Institutes of Health (both independent investigator grants and a Research Career Development Award), the American Heart Association (AHA), the National Collegiate Athletic Association (NCAA), the Office of Naval Research, the U.S. Air Force, the Department of Defense and the Environmental Protection Agency (EPA). In addition, he was principal investigator on an NIGMS-funded R25 Minority Bridging Award, which was designed to attract Master of Science graduates from the University of Arkansas at Pine Bluff, a primarily minority campus in the Delta region of Arkansas, to doctoral programs at UAMS, and an EPA-EPSCoR program designed to enhance toxicology research in Arkansas via enhanced electronic communications and pilot funding. Kennedy has served regularly on various peer-review groups including NIH, the AHA, the Veterans Affairs (VA) Merit Program, the American Diabetes Association and the British Columbia Health Care Research Foundation.

Awards & Recognition

  • St. Louis Pharmacists Association Award, 1975.
  • Maude Hammond Fling Fellowship, University of Nebraska, 1976 and 1977.
  • Franklin E. and Orinda M. Johnson Fellowship, University of Nebraska, 1978.
  • Pharmaceutical Manufacturer's Association Advanced Predoctoral Fellowship, 1979.
  • Michigan Heart Association Postdoctoral Fellowship, 1981 and 1982.
  • Research Career Development Award, National Institute on Aging, 1985-1990.
  • Second Runner-Up: Sophomore Basic Science Golden Apple Award, UAMS, 1986-1987.
  • Sophomore Basic Science Golden Apple Award, UAMS, 1987-1988.
  • First-Runner-Up: Sophomore Basic Science Golden Apple Award, UAMS, 1990-1991.
  • First-Runner-Up: Sophomore Basic Science Golden Apple Award, UAMS, 1991-1992.
  • Arkansas Representative - American Pharmacopia Convention, 1994 - 2003
  • Outstanding Achievement Award, St. Louis College of Pharmacy Alumni Association, 2003.
  • American Association of Colleges of Pharmacy (AACP) representative to the American Association for the Advancement of Science (AAAS) Section on Pharmaceutical Sciences, 2004-2007. 
  • Biotechnology Industry Organization (BIO) 2010 Meeting Steering Committee, 2009 – 2010.
  • Chair, Steering Committee, Center for Management of Complex Chronic Care, Hines Veterans Administration Hospital, 2010 – 2013.
  • Meeting Chair, Heparin Related Glycosaminoglycans and Glycomimetics: Impact of Biosimilar Regulations on Clinical Development, Sao Paulo, Brazil, April, 2010.
  • Member, Steering Committee, Center for Innovation for Complex Chronic Healthcare, Hines Veterans Administration Hospital, 2013 – present.